Article: Phase 2 Discovery Awarded Grant For Biomarker To Measure Traumatic Head Injury.(Brief Article)

2001 DEC 3 - (NewsRx.com & NewsRx.net) -- Phase 2 Discovery, Inc., has been awarded a $107,090 Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Neurological Disorders and Stroke of the U.S. National Institutes of Health (NIH).

This grant will support Phase 2 Discovery in the development of a serum-based biomarker that will predict the clinical outcome and quantify the effectiveness of new drugs for treating patients with severe head injury. According to company estimates, the market for this new diagnostic could be up to $22 million.

"Currently, there is no biomarker available for quantifying and monitoring the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!